Walleye Trading
JAZZ icon

Walleye Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

Walleye Trading’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132K Sell
700
-4,700
-87% -$821K ﹤0.01% 3327
2025
Q4 		$918K Buy
+5,400
New +$828K ﹤0.01% 2433
2024
Q3 		– Sell
-400
Closed -$42.7K – 4342
2024
Q2 		$42.7K Sell
400
-300
-43% -$33K ﹤0.01% 3642
2024
Q1 		$84.3K Sell
700
-1,100
-61% -$135K ﹤0.01% 3836
2023
Q4 		$221K Sell
1,800
-6,100
-77% -$761K ﹤0.01% 3704
2023
Q3 		$1.02M Sell
7,900
-2,600
-25% -$346K ﹤0.01% 2341
2023
Q2 		$1.3M Buy
10,500
+3,700
+54% +$498K ﹤0.01% 1959
2023
Q1 		$995K Sell
6,800
-42,600
-86% -$6.3M ﹤0.01% 2199
2022
Q4 		$7.87M Sell
49,400
-2,700
-5% -$396K 0.02% 801
2022
Q3 		$6.94M Buy
52,100
+4,100
+9% +$623K 0.02% 811
2022
Q2 		$7.49M Sell
48,000
-508
-1% -$78.2K 0.02% 790
2022
Q1 		$7.55M Sell
48,508
-3,244
-6% -$471K 0.02% 757
2021
Q4 		$6.59M Sell
51,752
-30,500
-37% -$4.01M 0.02% 817
2021
Q3 		$10.7M Buy
82,252
+1,600
+2% +$242K 0.04% 521
2021
Q2 		$14.3M Buy
80,652
+64,952
+414% +$11.3M 0.06% 313
2021
Q1 		$2.58M Buy
15,700
+15,100
+2,517% +$2.48M 0.01% 1128
2020
Q4 		$99K Sell
600
-1,000
-63% -$149K ﹤0.01% 3938
2020
Q3 		$228K Sell
1,600
-700
-30% -$86.8K ﹤0.01% 2910
2020
Q2 		$254K Sell
2,300
-5,100
-69% -$564K ﹤0.01% 2885
2020
Q1 		$738K Sell
7,400
-1,100
-13% -$142K 0.01% 1542
2019
Q4 		$1.27M Sell
8,500
-100
-1% -$13.6K 0.01% 1594
2019
Q3 		$1.1M Buy
8,600
+3,800
+79% +$509K 0.01% 1522
2019
Q2 		$684K Sell
4,800
-16,900
-78% -$2.27M 0.01% 1922
2019
Q1 		$3.1M Buy
21,700
+3,700
+21% +$483K 0.02% 768
2018
Q4 		$2.23M Sell
18,000
-48,000
-73% -$7.12M 0.02% 991
2018
Q3 		$11.1M Buy
66,000
+36,700
+125% +$6.31M 0.06% 296
2018
Q2 		$5.05M Buy
29,300
+25,600
+692% +$4.18M 0.03% 600
2018
Q1 		$559K Sell
3,700
-2,200
-37% -$323K ﹤0.01% 2537
2017
Q4 		$793 Buy
5,900
+4,000
+211% +$555K ﹤0.01% 2164
2017
Q3 		$278 Sell
1,900
-800
-30% -$121K ﹤0.01% 2970
2017
Q2 		$421 Sell
2,700
-7,400
-73% -$1.13M ﹤0.01% 2533
2017
Q1 		$1.47K Buy
10,100
+7,300
+261% +$951K 0.01% 1319
2016
Q4 		$307K Sell
2,800
-2,900
-51% -$323K ﹤0.01% 2486
2016
Q3 		$693K Buy
5,700
+3,300
+138% +$445K ﹤0.01% 1850
2016
Q2 		$339K Sell
2,400
-9,800
-80% -$1.44M ﹤0.01% 2546
2016
Q1 		$1.59M Buy
12,200
+9,200
+307% +$1.15M 0.01% 1018
2015
Q4 		$421K Buy
3,000
+100
+3% +$13.9K ﹤0.01% 2022
2015
Q3 		$387K Sell
2,900
-900
-24% -$155K ﹤0.01% 1759
2015
Q2 		$669K Buy
3,800
+100
+3% +$18K 0.01% 1428
2015
Q1 		$641K Buy
+3,700
New +$635K 0.01% 1308

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Walleye Trading's JAZZ Position: Q1 2026 in Review

Walleye Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 3,591 shares — an estimated $628K sold.

Walleye Trading first reported a position in JAZZ in Q2 2015 and held it in 23 quarters. The position peaked at $3.07M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Walleye Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 3,591 Jazz Pharmaceuticals shares in Q1 2026, an estimated $628K.
  • Walleye Trading first reported a position in Jazz Pharmaceuticals in Q2 2015 and held it in 23 quarters.
  • Walleye Trading's Jazz Pharmaceuticals position peaked at $3.07M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.